According to the report “Insulin Delivery Devices Market” published by Market Data Forecast, the global market is projected to reach USD 14.10 billion by 2020, at a CAGR of 6.99% from 2015 to 2020.
For full report refer at http://www.marketdataforecast.com/market-reports/global-insulin-delivery-devices-market-258/
Insulin maintains sugar levels in the blood and essential for the people suffering from type I diabetes & type II diabetes. The development of insulin delivery devices has been encouraged from the past years. These devices are used to deliver the insulin doses via parenteral route rather than oral route of administration. Insulin delivery devices promote absorption rate of insulin into blood stream from the site of injection to execute immediate pharmacological action of insulin. Some of the majorly used insulin delivery devices such as insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors.
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-insulin-delivery-devices-market-258/request-sample
Global insulin delivery devices market is expected to witness growth owing to growing rate of diabetes patients, rising exposure of population towards the diabetes risk factors, changes in lifestyle habits, and increasing demand for human insulin. In addition, availability of favorable medical reimbursements, increasing healthcare expenditure, rising advancements in human insulin delivery devices technologies, growing focus of market players on the development & commercialization of advanced human insulin delivery devices (such as pens & portable insulin pumps) are further fueling the growth of global insulin delivery devices market.
1)On the basis of Type
•Insulin Pen Needles
•Insulin Jet Injectors
2)On the basis of Application
•Type I Diabetes
•Type II Diabetes
3)On the basis of Geography
•Middle East & Africa
The key players in global insulin delivery devices market such as, Becton, Dickinson and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland), and Biodel Inc. (U.S.).
About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Market Data Forecast, Inc.
+1-888-702-9626 (U.S. TOLL FREE)